Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-κB

Journal of Virology

Volumn 85, Issue 11, 2011, Pages 5483-5493

  Wang, Xiao Mei ^a   Nadeau, Peter E ^a   Lin, Shanshan ^a   Abbott, Jeffrey R ^a   Mergia, Ayalew ^a  

^a University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CD4 ANTIGEN; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA;

ARTICLE; CD4+ T LYMPHOCYTE; CELL NUCLEUS; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; TRANSCRIPTION REGULATION; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION;

CAVEOLIN 1; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GENE EXPRESSION PROFILING; HIV-1; HUMANS; MACROPHAGES; NF-KAPPA B; PROTEIN BIOSYNTHESIS; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79956074062     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00254-11     Document Type: Article

References (62)

1. Adachi, A., et al. 1987. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J. Virol. 61:209-213.
2. Asin, S., G. D. Bren, E. M. Carmona, N. J. Solan, and C. V. Paya. 2001. NF-κB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages. J. Virol. 75:11408-11416.
3. Asin, S., J. A. Taylor, S. Trushin, G. Bren, and C. V. Paya. 1999. Iκκ mediates NF-κB activation in human immunodeficiency virus-infected cells. J. Virol. 73:3893-3903.
4. Bellyei, S., et al. 2010. GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro. Cancer Lett. 293:31-40.
5. Bergamaschi, A., and G. Pancino. 2010. Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 7:31.
6. Burgermeister, E., M. Liscovitch, C. Rocken, R. M. Schmid, and M. P. Ebert. 2008. Caveats of caveolin-1 in cancer progression. Cancer Lett. 268:187-201.
7. Burgermeister, E., et al. 2007. Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Res. 67:8519-8526.
8. Coiras, M., M. R. Lopez-Huertas, M. Perez-Olmeda, and J. Alcami. 2009. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat. Rev. Microbiol. 7:798-812.
9. Coiras, M., M. R. Lopez-Huertas, J. Rullas, M. Mittelbrunn, and J. Alcami. 2007. Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression. Retrovirology 4:56.
10. Coombs, R. W., et al. 1989. Plasma viremia in human immunodeficiency virus infection. N. Engl. J. Med. 321:1626-1631.
11. Couet, J., S. Li, T. Okamoto, T. Ikezu, and M. P. Lisanti. 1997. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 272:6525-6533.
12. Cullen, B. R. 1991. Regulation of HIV-1 gene expression. FASEB J. 5:2361-2368.
13. D'Alessio, A., et al. 2010. Targeting of tumor necrosis factor receptor 1 to low density plasma membrane domains in human endothelial cells. J. Biol. Chem. 285:23868-23879.
14. Dupree, P., R. G. Parton, G. Raposo, T. V. Kurzchalia, and K. Simons. 1993. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J. 12:1597-1605.
15. Frank, P. G., S. Pavlides, M. W. Cheung, K. Daumer, and M. P. Lisanti. 2008. Role of caveolin-1 in the regulation of lipoprotein metabolism. Am. J. Physiol. Cell Physiol. 295:C242-C248.
16. Frank, P. G., S. Pavlides, and M. P. Lisanti. 2009. Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell Tissue Res. 335:41-47.
17. Gargalovic, P., and L. Dory. 2003. Caveolins and macrophage lipid metabolism. J. Lipid Res. 44:11-21.
18. Goetz, J. G., P. Lajoie, S. M. Wiseman, and I. R. Nabi. 2008. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev. 27:715-735.
19. Harris, J., et al. 2002. Expression of caveolin by bovine lymphocytes and antigen-presenting cells. Immunology 105:190-195.
20. 2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:6705-6711.
21. Hovanessian, A. G., et al. 2004. The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection. Immunity 21:617-627.
22. Huang, J., et al. 2008. Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 294:L1250-L1259.
23. Huang, J. H., et al. 2007. Identification of the HIV-1 gp41 core-binding motif in the scaffolding domain of caveolin-1. J. Biol. Chem. 282:6143-6152.
24. Jeeninga, R. E., et al. 2000. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J. Virol. 74:3740-3751.
25. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:621-663.
26. Kilareski, E. M., S. Shah, M. R. Nonnemacher, and B. Wigdahl. 2009. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 6:118.
27. Kogo, H., and T. Fujimoto. 2000. Caveolin-1 isoforms are encoded by distinct mRNAs. Identification of mouse caveolin-1 mRNA variants caused by alternative transcription initiation and splicing. FEBS Lett. 465:119-123.
28. Kurzchalia, T. V., et al. 1992. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J. Cell Biol. 118:1003-1014.
29. Kurzchalia, T. V., and R. G. Parton. 1999. Membrane microdomains and caveolae. Curr. Opin. Cell Biol. 11:424-431.
30. Le Douce, V., G. Herbein, O. Rohr, and C. Schwartz. 2010. Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology 7:32.
31. Lin, S., X. M. Wang, P. E. Nadeau, and A. Mergia. 2010. HIV infection upregulates caveolin 1 expression to restrict virus production. J. Virol. 84: 9487-9496.
32. Lisanti, M. P., et al. 1995. Caveolae, transmembrane signalling and cellular transformation. Mol. Membr. Biol. 12:121-124.
33. Liu, P., M. Rudick, and R. G. Anderson. 2002. Multiple functions of caveolin-J. Biol. Chem. 277:41295-41298.
34. Llano, M., et al. 2002. Blockade of human immunodeficiency virus type 1 expression by caveolin-1. J. Virol. 76:9152-9164.
35. Margolis, D. M. 2010. Mechanisms of HIV latency: an emerging picture of complexity. Curr. HIV/AIDS Rep. 7:37-43.
36. Mercier, I., et al. 2009. Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Lab Invest. 89:614-623.
37. Mingyan, Y., L. Xinyong, and E. De Clercq. 2009. NF-kappaB: the inducible factors of HIV-1 transcription and their inhibitors. Mini Rev. Med. Chem. 9:60-69.
38. Mirza, M. K., et al. 2010. Caveolin-1 deficiency dampens Toll-like receptor 4 signaling through eNOS activation. Am. J. Pathol. 176:2344-2351.
39. Molina, J. M., D. T. Scadden, R. Byrn, C. A. Dinarello, and J. E. Groopman. 1989. Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. J. Clin. Invest. 84:733-737.
40. Mukerjee, R., B. E. Sawaya, K. Khalili, and S. Amini. 2007. Association of p65 and C/EBPbeta with HIV-1 LTR modulates transcription of the viral promoter. J. Cell. Biochem. 100:1210-1216.
41. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713.
42. Okamoto, T., A. Schlegel, P. E. Scherer, and M. P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:5419-5422.
43. Palade, G. E. 1953. Fine structure of blood capillaries. J. Appl. Phys 24:1424.
44. Parent, M., et al. 2005. Poly(ADP-ribose) polymerase-1 is a negative regulator of HIV-1 transcription through competitive binding to TAR RNA with Tat. positive transcription elongation factor b (p-TEFb) complex. J. Biol. Chem. 280:448-457.
45. Park, J., P. E. Nadeau, and A. Mergia. 2009. Activity of TAR in inducible inhibition of HIV replication by foamy virus vector expressing siRNAs under the control of HIV LTR. Virus Res. 140:112-120.
46. Parton, R. G., and K. Simons. 2007. The multiple faces of caveolae. Nat. Rev. Mol. Cell. Biol. 8:185-194.
47. Pelkmans, L., J. Kartenbeck, and A. Helenius. 2001. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3:473-483.
48. Poli, G., et al. 1990. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. U. S. A. 87:782-785.
49. Pomerantz, R. J., M. B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172:253-261.
50. Quest, A. F., J. L. Gutierrez-Pajares, and V. A. Torres. 2008. Caveolin-1: an ambiguous partner in cell signalling and cancer. J. Cell. Mol. Med. 12:1130-1150.
51. Quest, A. F., L. Leyton, and M. Parraga. 2004. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem. Cell Biol. 82:129-144.
52. Sen, J., et al. 1995. Expression and induction of nuclear factor-kappa B-related proteins in thymocytes. J. Immunol. 154:3213-3221.
53. Shin, J. S., Z. Gao, and S. N. Abraham. 2000. Involvement of cellular caveolae in bacterial entry into mast cells. Science 289:785-788.
54. Stan, R. V. 2005. Structure of caveolae. Biochim. Biophys. Acta 1746:334-348.
55. Stan, R. V., E. Tkachenko, and I. R. Niesman. 2004. PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms. Mol. Biol. Cell 15:3615-3630.
56. Verhoef, K., R. W. Sanders, V. Fontaine, S. Kitajima, and B. Berkhout. 1999. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site. J. Virol. 73:1331-1340.
57. Wang, X. M., H. P. Kim, R. Song, and A. M. Choi. 2006. Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway. Am. J. Respir. Cell Mol. Biol. 34:434-442.
58. Wang, X. M., P. E. Nadeau, Y. T. Lo, and A. Mergia. 2010. Caveolin-1 modulates HIV-1 envelope-induced bystander apoptosis through gp41. J. Virol. 84:6515-6526.
59. Williams, S. A., H. Kwon, L. F. Chen, and W. C. Greene. 2007. Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1. J. Virol. 81:6043-6056.
60. Williams, T. M., and M. P. Lisanti. 2005. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell Physiol. 288:C494-C506.
61. Yamada, E. 1955. The fine structure of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol. 1:445-458.
62. Zheng, Y., et al. 2009. Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation. J. Nutr. Biochem. 20:202-209.